Artesunate-60 mg Injection Injection | PCD Pharma Manufacturer & Supplier India | Trumac Healthcare
Artesunate-60 mg Injection Injection
WHO-GMP Manufacturer & PCD Pharma Franchise Supplier in India
Form: Injection
Class: Artemisinin (Severe Malaria)
✓ Pan-India Monopoly PCD
✓ 1 Brand Options
Pricing, brochure & monopoly territory within 24 hrs.
Our Artesunate-60 mg Injection Injection Brand Options (1 option)
Trumac Healthcare manufactures and supplies the following Artesunate-60 mg Injection Injection brands for PCD pharma distribution. Click any brand to view full specifications and packaging.
Artesunate-60 mg Injection Injection is manufactured under WHO-GMP-certified conditions by Trumac Healthcare and supplied for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across India. Whether you are a PCD distributor, stockist or retail chemist, our Artesunate-60 mg Injection formulation comes with full quality assurance, regulatory documentation and reliable pan-India despatch.
Therapeutic Indications
- Severe falciparum malaria (WHO first-line)
- Cerebral malaria
- Severe P. vivax with high parasitaemia
Mechanism of Action
Artesunate is a water-soluble artemisinin derivative — produces toxic free radicals that damage malaria parasite proteins, particularly during early stage. WHO first-line for severe falciparum malaria. Rapid parasite clearance and improved mortality vs quinine in severe malaria.
Dosage & Administration
- Adults: 2.4 mg/kg IV at 0, 12, 24 hours then once daily.
- Children: 3 mg/kg.
Side Effects
- Generally well tolerated.
- Rare neurotoxicity at very high doses, mild GI upset, transient transaminase elevation, post-artemisinin delayed haemolysis (PADH).
Contraindications
- First trimester pregnancy (relative — benefit may outweigh risk in severe malaria), severe hypersensitivity.
Storage
Store between 2–25 °C, protect from light.
PCD Pharma Franchise for Artesunate-60 mg Injection Injection
- ✓ WHO-GMP certified manufacturing facility
- ✓ Pan-India monopoly distribution rights available
- ✓ Multiple pack sizes: Vial + Water (Tray Pack)
- ✓ Trade-friendly PTR / PTS margins
- ✓ Free promotional material on request
- ✓ Full DCGI documentation and quality certificates supplied
Trumac Healthcare offers 1 brand option for Artesunate-60 mg Injection Injection — each available in different pack sizes with trade-friendly margins. View the brand-specific pages below for detailed specifications, MRPs and packaging options.
For PCD franchise opportunities, monopoly distribution rights, or third-party contract manufacturing of Artesunate-60 mg Injection Injection, contact our business development team. WhatsApp +91 9041677932 or email info@trumachealthcare.net.
Frequently Asked Questions
Who is the manufacturer of Artesunate-60 mg Injection Injection?
Trumac Healthcare is a WHO-GMP certified manufacturer of Artesunate-60 mg Injection Injection in India. We supply our own brand range (see brand options above) and also offer third-party contract manufacturing for PCD distributors.
Is Artesunate-60 mg Injection Injection available for PCD pharma franchise on monopoly basis?
Yes. We offer Artesunate-60 mg Injection Injection for PCD/Propaganda-cum-Distribution pharma franchise on monopoly basis across all districts of India. Contact our business development team for pricing and territory availability.
What pack sizes are available for Artesunate-60 mg Injection Injection?
Available pack sizes include: Vial + Water (Tray Pack).
What is the MRP / trade price for Artesunate-60 mg Injection Injection?
MRPs range from ₹215 to ₹215 across our brand variants. Trade-friendly PTR/PTS margins available on request — WhatsApp +91 9041677932 for current rates.
How do I place an order or franchise enquiry?
WhatsApp +91 9041677932 or email info@trumachealthcare.net with your enquiry. Our team will revert within 24 hours with full pricing, brochure and franchise terms.
Ready to start your PCD franchise for Artesunate-60 mg Injection Injection?